Fresenius Medical Care AG & Co KGaA
XETRA:FME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Fresenius Medical Care AG & Co KGaA (FME) under the Base Case is EUR per share. Compared with the current market price of 40.72 EUR, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Fresenius Medical Care AG & Co KGaA Does
Fresenius Medical Care is a kidney care company. It runs dialysis clinics where patients with kidney failure receive regular treatment, and it also makes and sells the dialysis machines, filters, and related supplies used in those treatments. Its business sits at the center of chronic kidney care, serving both patients directly and the healthcare providers that treat them.
- Headquarters
- Germany DE
- Employees
- 122 909
- IPO date
- Oct 2, 1996
Fresenius Medical Care AG & Co KGaA has no economic moat
Patients and healthcare buyers can choose among several dialysis providers and equipment makers; more people using Fresenius does not, by itself, make its services more valuable to other patients. Its size has not made it the sole or unavoidable provider in the markets it serves.
Read the full moat analysis
Revenue & Expenses Breakdown
Fresenius Medical Care AG & Co KGaA
Earnings Waterfall
Fresenius Medical Care AG & Co KGaA
What is the Intrinsic Value of one FME stock?
The intrinsic value for Fresenius Medical Care AG & Co KGaA (FME) under the Base Case is EUR.
Is FME stock undervalued or overvalued?
Compared with the current market price of 40.72 EUR, the stock appears .